SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹6.31 Cr | ₹4.98 Cr | ₹4.42 Cr | ₹4.58 Cr | ₹7.16 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹6.31 Cr |
| Mar2024 | ₹4.98 Cr |
| Mar2023 | ₹4.42 Cr |
| Mar2022 | ₹4.58 Cr |
| Mar2017 | ₹7.16 Cr |
How is Deferred Tax Assets / Liabilities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹6.31 Cr | 26.80 | |
| Mar2024 | ₹4.98 Cr | 12.55 | |
| Mar2023 | ₹4.42 Cr | -3.34 | |
| Mar2022 | ₹4.58 Cr | -36.07 | |
| Mar2017 | ₹7.16 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,276.5 Cr | 15.8% | 14.5% | -26.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 15.8% |
14.5% |
-26.8% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses